A critical factor in determining how much glutathione is in the lens nucleus may be the so-called lens barrier, which has been described by the Truscott laboratory
Semaglutide, marketed as Ozempic, Rybelsus, and Wegovy, is an FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management
Because whilst the potential pain benefits are interesting, there are specific reasons why the hypermobility and Ehlers-Danlos population needs to approach GLP-1 drugs with considerably more caution than the general public
If GLP-1 treatment is discontinued and weight remains stable, metabolic rate typically stays consistent with your current body mass
Both compounds represent powerful tools for optimizing cellular function when used appropriately under expert guidance
Protein supplementation during GLP-1 treatment can further support muscle preservation